Bayer is deploying GenAI tools at scale while many corporates struggle to find ROI on AI. The difference may lie in a 12-year ...
All wheelchair accessible tickets are located to the right of the away section. The entry process is via Gate H3 (See Map ...
German conglomerate Bayer on Wednesday said it will sell a new soybean product called Intacta 5+ for farmers in Brazil, the ...
Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...
A new oral HER2-directed breast cancer therapy from Bayer AG, and its companion diagnostic from Thermo Fisher Scientific Inc., have been approved by the U.S. FDA. Hyrnuo (sevabertinib), a reversible ...
Bayer (BAYZF) stock is in focus as the FDA grants accelerated approval for the company's tumor drug Hyrnuo in non-squamous ...
The leaders said the company’s collaborative culture keeps patient benefit at the center of decision-making. To learn more about how Bayer’s model is transforming its pipeline, listen to the full ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
A federal judge in San Francisco gave final approval to a $38 million class action settlement in a case against Bayer over investors’ claims that it didn’t conduct due diligence before making a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback